First Horizon Advisors Inc. Trims Holdings in Stevanato Group S.p.A. (NYSE:STVN)

First Horizon Advisors Inc. decreased its holdings in Stevanato Group S.p.A. (NYSE:STVN) by 26.3% in the 4th quarter, Holdings Channel reports. The firm owned 3,098 shares of the company’s stock after selling 1,107 shares during the period. First Horizon Advisors Inc.’s holdings in Stevanato Group were worth $68,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently bought and sold shares of STVN. TimesSquare Capital Management LLC raised its position in Stevanato Group by 114.6% in the 4th quarter. TimesSquare Capital Management LLC now owns 3,288,529 shares of the company’s stock valued at $71,657,000 after purchasing an additional 1,756,100 shares during the last quarter. Thrivent Financial for Lutherans raised its position in Stevanato Group by 67.6% in the 3rd quarter. Thrivent Financial for Lutherans now owns 2,784,912 shares of the company’s stock valued at $55,698,000 after purchasing an additional 1,123,104 shares during the last quarter. Jennison Associates LLC purchased a new stake in Stevanato Group in the 4th quarter valued at $20,239,000. Pembroke Management LTD raised its position in Stevanato Group by 143.7% in the 3rd quarter. Pembroke Management LTD now owns 1,051,140 shares of the company’s stock valued at $21,023,000 after purchasing an additional 619,747 shares during the last quarter. Finally, New York State Common Retirement Fund purchased a new stake in Stevanato Group in the 4th quarter valued at $8,879,000.

Stevanato Group Stock Performance

NYSE:STVN opened at €19.51 ($20.32) on Friday. The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22. Stevanato Group S.p.A. has a fifty-two week low of €16.56 ($17.25) and a fifty-two week high of €34.00 ($35.42). The stock has a market cap of $5.91 billion, a PE ratio of 41.51, a price-to-earnings-growth ratio of 7.18 and a beta of 0.56. The firm’s fifty day simple moving average is €21.59 and its 200-day simple moving average is €20.55.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the stock. Bank of America boosted their price objective on shares of Stevanato Group from $24.00 to $26.00 and gave the company a “buy” rating in a research note on Friday, December 13th. Wolfe Research assumed coverage on shares of Stevanato Group in a research note on Friday, December 13th. They issued an “outperform” rating and a $28.00 price objective on the stock. Finally, Morgan Stanley reissued an “equal weight” rating and issued a $23.00 price objective (down from $24.00) on shares of Stevanato Group in a research note on Tuesday, December 3rd. One research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, Stevanato Group currently has an average rating of “Moderate Buy” and an average target price of €28.60 ($29.79).

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.